AAAAAA

   
Results: 1-24 |
Results: 24

Authors: VALADON P NUSSBAUM G OH J SCHARFF MD
Citation: P. Valadon et al., ASPECTS OF ANTIGEN MIMICRY REVEALED BY IMMUNIZATION WITH A PEPTIDE MIMETIC OF CRYPTOCOCCUS-NEOFORMANS POLYSACCHARIDE, The Journal of immunology (1950), 161(4), 1998, pp. 1829-1836

Authors: ALLHOFF T NUSSBAUM G REICHMANN I
Citation: T. Allhoff et al., ERYTHEMA EXSUDATIVUM MULTIFORME MAJUS IN THE EARLY STAGES OF DETOXIFICATION OF AN ADDICT, Allergologie, 20(7), 1997, pp. 340-344

Authors: KASPAR R GONZALEZBAQUET I RICHTER J NUSSBAUM G KOTHE A
Citation: R. Kaspar et al., NEW POST FORGING TREATMENT OF MEDIUM-CARBON MICROALLOYED STEELS, Steel research, 68(6), 1997, pp. 266-271

Authors: GONZALEZBAQUET I KASPAR R RICHTER J NUSSBAUM G KOTHE A
Citation: I. Gonzalezbaquet et al., INFLUENCE OF MICROALLOYING ON THE MECHANICAL-PROPERTIES OF MEDIUM-CARBON FORGING STEELS AFTER A NEWLY DESIGNED POST FORGING TREATMENT, Steel research, 68(12), 1997, pp. 534-540

Authors: KASPAR R GONZALEZBAQUET I SCHREIBER N RICHTER J NUSSBAUM G KOTHE A
Citation: R. Kaspar et al., APPLICATION OF THERMOMECHANICAL TREATMENT ON MEDIUM-CARBON MICROALLOYED STEELS CONTINUOUSLY COOLED FROM FORGING TEMPERATURE, Steel research, 68(1), 1997, pp. 27-31

Authors: NUSSBAUM G CLEARE W CASADEVALL A SCHARFF MD VALADON P
Citation: G. Nussbaum et al., EPITOPE LOCATION IN THE CRYPTOCOCCUS-NEOFORMANS CAPSULE IS A DETERMINANT OF ANTIBODY EFFICACY, The Journal of experimental medicine, 185(4), 1997, pp. 685-694

Authors: OCKENFELS HM NUSSBAUM G SCHNECK B WAGNER SN HAEN E GOOS M
Citation: Hm. Ockenfels et al., THE EFFECT OF CYCLOSPORINE-A AND FK-506 ON THE CAMP CONTENT IN PSORIATIC KERATINOCYTES, Skin pharmacology, 9(4), 1996, pp. 281-288

Authors: SANCHEZ C NUSSBAUM G AZAVANT P OCTOR H
Citation: C. Sanchez et al., ELEVATED-TEMPERATURE BEHAVIOR OF RAPIDLY SOLIDIFIED MAGNESIUM ALLOYS CONTAINING RARE-EARTHS, Materials science & engineering. A, Structural materials: properties, microstructure and processing, 221(1-2), 1996, pp. 48-57

Authors: OCKENFELS HM WAGNER SN KEIMMAAS C FUNK R NUSSBAUM G GOOS M
Citation: Hm. Ockenfels et al., LITHIUM AND PSORIASIS - CYTOKINE MODULATION OF CULTURED LYMPHOCYTES AND PSORIATIC KERATINOCYTES BY LITHIUM, Archives of dermatological research, 288(4), 1996, pp. 173-178

Authors: OCKENFELS HM WAGNER SN OELJEKLAUS P SCHNECK B NUSSBAUM G JAKOBS KH GOOS M
Citation: Hm. Ockenfels et al., INHIBITION OF T-CELL CAMP FORMATION BY CYCLOSPORINE-A AND FH506, Naunyn-Schmiedeberg's archives of pharmacology, 353(5), 1996, pp. 513-516

Authors: VALADON P NUSSBAUM G BOYD LF MARGULIES DH SCHARFF MD
Citation: P. Valadon et al., PEPTIDE LIBRARIES DEFINE THE FINE SPECIFICITY OF ANTI-POLYSACCHARIDE ANTIBODIES TO CRYPTOCOCCUS-NEOFORMANS, Journal of Molecular Biology, 261(1), 1996, pp. 11-22

Authors: DIETSCH M WAGNER SN WAGNER C NUSSBAUM G MORRIS SW GOOS M
Citation: M. Dietsch et al., NUCLEOPHOSMIN (NPM) GENE REARRANGEMENTS IN CD-30-POSITIVE CUTANEOUS LYMPHOMAS, Journal of investigative dermatology, 107(3), 1996, pp. 318-318

Authors: NUSSBAUM G YUAN RR CASADEVALL A SCHARFF MD
Citation: G. Nussbaum et al., IMMUNOGLOBULIN G3 BLOCKING ANTIBODIES TO THE FUNGAL PATHOGEN CRYPTOCOCCUS-NEOFORMANS, The Journal of experimental medicine, 183(4), 1996, pp. 1905-1909

Authors: SPIRA G PAIZI M MAZAR S NUSSBAUM G MUKHERJEE S CASADEVALL A
Citation: G. Spira et al., GENERATION OF BIOLOGICALLY-ACTIVE ANTI-CRYPTOCOCCUS NEOFORMANS IGG, IGE AND IGA ISOTYPE SWITCH VARIANT ANTIBODIES BY ACRIDINE-ORANGE MUTAGENESIS, Clinical and experimental immunology, 105(3), 1996, pp. 436-442

Authors: OCKENFELS HM KEIMMAAS C FUNK R NUSSBAUM G GOOS M
Citation: Hm. Ockenfels et al., ETHANOL ENHANCES THE IFN-GAMMA, TGF-ALPHA AND IL-6 SECRETION IN PSORIATIC COCULTURES, British journal of dermatology, 135(5), 1996, pp. 746-751

Authors: APHASIZHEV R SENGER B RENGERS JU SPRINZL M WALTER P NUSSBAUM G FASIOLO F
Citation: R. Aphasizhev et al., CONSERVATION IN EVOLUTION FOR A SMALL MONOMERIC PHENYLALANYL-TRANSFER-RNA SYNTHETASE OF THE TRNA(PHE) RECOGNITION NUCLEOTIDES AND INITIAL AMINOACYLATION SITE, Biochemistry, 35(1), 1996, pp. 117-123

Authors: OCKENFELS HM NUSSBAUM G SCHULTEWOLTER T MERTINS K WAGNER SN GOOS M
Citation: Hm. Ockenfels et al., TYROSINE PHOSPHORYLATION IN PSORIATIC T-CELLS IS MODULATED BY DRUGS THAT INDUCE OR IMPROVE PSORIASIS, Dermatology, 191(3), 1995, pp. 217-225

Authors: YUAN RR CASADEVALL A NUSSBAUM G SPIRA G SCHARFF MD
Citation: Rr. Yuan et al., NON-PROTECTIVE IGG3 MONOCLONAL-ANTIBODIES (MABS) TO C-NEOFORMANS IN THE MOUSE, The FASEB journal, 9(3), 1995, pp. 207-207

Authors: OCKENFELS HM NUSSBAUM G SCHULTEWOLTER T BURGER PM GOOS M
Citation: Hm. Ockenfels et al., CYCLOSPORINE-A, FH506 AND DITHRANOL ALTER TYROSINE-SPECIFIC PROTEIN-PHOSPHORYLATION IN HACAT KERATINOCYTES, Archives of dermatological research, 287(3-4), 1995, pp. 304-309

Authors: OCKENFELS HM WAGNER SN KAIMMAAS C NUSSBAUM G GOOS M
Citation: Hm. Ockenfels et al., PROPRANOLOL AND LITHIUM INFLUENCE THE PSORIATIC CYTOKINE NETWORK, Journal of investigative dermatology, 104(4), 1995, pp. 682-682

Authors: MUKHERJEE J NUSSBAUM G SCHARFF MD CASADEVALL A
Citation: J. Mukherjee et al., PROTECTIVE AND NONPROTECTIVE MONOCLONAL-ANTIBODIES TO CRYPTOCOCCUS-NEOFORMANS ORIGINATING FROM ONE B-CELL, The Journal of experimental medicine, 181(1), 1995, pp. 405-409

Authors: SMITH DS AVEDIKIAN R BOURG P LAVAL A NUSSBAUM G BORIE JM
Citation: Ds. Smith et al., ELECTRICAL BEHAVIOR OF COMPRESSED MAGNESIA POWDER, Journal of Materials Science, 29(24), 1994, pp. 6473-6478

Authors: OCKENFELS HM OELJEKLAUS P WAGNER S SCHNECK B NUSSBAUM G GOOS M
Citation: Hm. Ockenfels et al., IMMUNOSUPPRESSIVE DRUGS DOWN-REGULATE CAMP LEVEL IN T-LYMPHOCYTES OF PSORIATIC PATIENTS, Journal of investigative dermatology, 103(3), 1994, pp. 404-404

Authors: OCKENFELS HM OELJEKLAUS P SCHNECK B NUSSBAUM G GOOS M
Citation: Hm. Ockenfels et al., CYCLIC-AMP IS MARKEDLY ALTERED IN T-LYMPHOCYTES BY PSORIASIS PROVOKING AND ANTIPSORIATIC DRUGS, Journal of investigative dermatology, 102(4), 1994, pp. 627-627
Risultati: 1-24 |